Pulmicort flexhaler (Budesonide)

Brand Options

arrow pointer

Brand Name : Pulmicort flexhaler

Marketing Authorization Holder : AstraZeneca

Prescription Required

 
 

Generic Option

arrow pointer2

Generic Name : Budesonide

Manufactured By : Authorized UK Generic

Prescription Required

 
 

Product Details

Pulmicort flexhaler

If you do not have a Doctor, we can provide a service for a physician review. Just open and complete the following form:

https://form.jotform.com/202321099620447

Information about Pulmicort Flexhaler (Budesonide)

Pulmicort flexhale delivers 90mcg per dose, equivalent to 100mcg dose.  The difference is how the medicine is measured.  Both products deliver the identical amount of medicine per actuation.

Pulmicort Flexhaler is the brand name for Budesonide, a corticosteroid used to manage asthma and chronic obstructive pulmonary disease (COPD). It works by reducing airway inflammation, which helps improve breathing. Pulmicort Flexhaler is delivered via an inhaler device and is typically used as a long-term maintenance treatment.

Product Highlights

  • Used as a maintenance therapy to control asthma symptoms and prevent asthma attacks by reducing airway inflammation.
  • Pulmicort is used as part of a treatment regimen for COPD to reduce airway inflammation and improve breathing.
  • Pulmicort is not used for immediate relief of sudden breathing problems but for long-term prevention and control of symptoms.

Key Ingredient

  • Budesonide

Key Benefits

  • Budesonide helps reduce inflammation in the lungs and airways, making it easier to breathe and preventing asthma or COPD flare-ups.
  • It is effective in preventing asthma attacks when used regularly as a maintenance therapy.
  • By controlling inflammation, Pulmicort helps to reduce wheezing, shortness of breath, and coughing in patients with asthma or COPD.
  • Unlike some other respiratory treatments, Pulmicort does not cause drowsiness, making it suitable for use during the day.
  • Since Pulmicort is inhaled, it has a lower risk of causing systemic side effects compared to oral steroids.

Direction of Use

  • Pulmicort Flexhaler is used with an inhaler device. The inhaler delivers a fine powder of budesonide directly into the lungs.
  • The usual starting dose for asthma is 180 mcg (one inhalation) twice daily, but your healthcare provider will determine the exact dose based on individual needs and response.
  • Inhale the medication deeply, hold your breath for 10 seconds, and then exhale gently. Always follow the instructions for your Flexhaler device to ensure the proper dose is delivered.
  • For best results, Pulmicort should be taken regularly at the same time each day, even if symptoms are not present.

Safety Concerns

  • Inhaled corticosteroids like Pulmicort may increase the risk of fungal infections in the mouth (oral thrush). It is recommended to rinse the mouth after using the inhaler to reduce this risk.
  • Prolonged use of corticosteroids can affect the adrenal glands, leading to decreased production of natural steroids. This is more likely if used in higher doses or for long periods.
  • Long-term use of inhaled corticosteroids has been associated with slight reductions in growth velocity in children. Regular monitoring by a doctor is recommended.
  • Prolonged use of Pulmicort may increase the risk of cataracts and glaucoma. Regular eye exams should be considered during long-term use.
  • Since corticosteroids suppress the immune system, they may increase susceptibility to infections.

Avoid Pulmicort Flexhaler (Budesonide) If

  • If you have a known allergy to budesonide or any of the components of the Pulmicort Flexhaler, avoid using this medication.
  • Pulmicort is not intended for the immediate relief of acute asthma attacks and should not be used as a rescue inhaler. 
  • If you have a systemic fungal infection, do not use Pulmicort as corticosteroids may worsen the condition.
  • Patients with active tuberculosis or other untreated infections should not use Pulmicort.
  • Caution is required in patients with severe liver disease, as the metabolism of budesonide may be affected.


Image Image Image Image